In the 15th and final chapter of its series on Johnson & Johnson’s Risperdal (risperidone), the Huffington Post (10/2) “Highline” recounts how the jury in the Pledger case handed down its verdict Feb. 24, 2015, finding J&J was negligent by failing to provide an adequate warning about the risk of […]
Risperdal
3 posts
By Buck Daniel – Recent developments in the Risperdal litigation include court-approved “short-form” plaintiff’s fact sheets (PFS) and a renewed push for the first bellwether trial in California. If we have filed your case, then attorney Buck Daniel has been trying to reach out to you in order to discuss […]
By Buck Daniel – Currently, we are placing our focus on two litigation fronts for our Risperdal cases. In the Philadelphia litigation there are hundreds of cases pending, whereas the California litigation is in its beginning stages. California Superior Judge William Highberger, who is overseeing the cases, along with the […]